Abionyx Pharma SA Financial Flexibility Index
Abionyx Pharma SA financial flexibility index. Abionyx Pharma SA (ABNX) has a Financial Flexibility Index of -0.20x as of June 2025. Free cash flow of €-1.54 Million (operating CF €-1.70 Million minus capex €162.00K) represents 0% of total liabilities (€7.56 Million). See Abionyx Pharma SA (ABNX) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Abionyx Pharma SA (2013–2024)
Financial flexibility index of Abionyx Pharma SA from 2013 to 2024. Historical Financial Flexibility Index trend for Abionyx Pharma SA across 12 annual periods. Check how high is Abionyx Pharma SA's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Abionyx Pharma SA Financial Flexibility Index by Year (2013–2024)
Abionyx Pharma SA financial flexibility index by year from 2013 to 2024. Year-by-year free cash flow to debt coverage for Abionyx Pharma SA. For the full cash flow conversion analysis, see Abionyx Pharma SA (ABNX) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.58x | €-3.52 Million | €-3.60 Million | €6.03 Million | ▼ -13.3% |
| 2023 | -0.52x | €-3.57 Million | €-3.70 Million | €6.91 Million | ▼ -40.3% |
| 2022 | -0.37x | €-3.18 Million | €-3.36 Million | €8.65 Million | ▲ +37.1% |
| 2021 | -0.59x | €-6.53 Million | €-6.69 Million | €11.15 Million | ▼ -374.6% |
| 2020 | -0.12x | €-451.00K | €-599.00K | €3.66 Million | ▲ +88.5% |
| 2019 | -1.07x | €-3.85 Million | €-3.95 Million | €3.58 Million | ▼ -67.0% |
| 2018 | -0.64x | €-5.98 Million | €-6.00 Million | €9.30 Million | ▲ +31.9% |
| 2017 | -0.94x | €-8.88 Million | €-9.09 Million | €9.41 Million | ▲ +28.9% |
| 2016 | -1.33x | €-19.19 Million | €-19.20 Million | €14.46 Million | ▼ -26.6% |
| 2015 | -1.05x | €-13.54 Million | €-13.71 Million | €12.91 Million | ▼ -244.1% |
| 2014 | -0.30x | €-3.30 Million | €-3.30 Million | €10.82 Million | ▲ +83.7% |
| 2013 | -1.87x | €-14.48 Million | €-14.49 Million | €7.76 Million | — |